As of August 28, 2026, Cardiol Therapeutics Inc. (CRDL) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Cardiol Therapeutics Inc. has a market capitalization of $140.63M, 65.35M shares outstanding, 46 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.32 approaching $1 threshold
Market Data
Market Cap$140.63M
Shares Outstanding65.35M
FloatN/A
Cash$20.06M
Debt$84.4K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 188.2% shares (2026Q1 vs prior)
46 institutional holders · 28.72M shares
#1
MMCAP International Inc. SPC
15.35M shares
#2
Tejara Capital Ltd
5.13M shares
#3
Ikarian Capital, LLC
2.73M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.25M
Days to Cover2.3
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CRDL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRDL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for CRDL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.